Ani Pharmaceuticals (ANIP) Shares Outstanding (2010 - 2026)

Ani Pharmaceuticals has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $23.9 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 6.86% year-over-year to $23.9 million; the TTM figure through Jun 2026 stood at $23.9 million (up 6.86% YoY), while the FY2025 annual figure was $22.5 million, up 6.55% from the prior year.
• Shares Outstanding (Entity) came in at $23.9 million for Q2 2026 at Ani Pharmaceuticals, roughly flat from $23.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $23.9 million in Q2 2026 to a low of $17.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $20.7 million, with a median of $21.2 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) surged 38.93% in 2022 and grew 1.82% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $17.5 million in 2022, then rose by 18.46% to $20.7 million in 2023, then climbed by 1.82% to $21.1 million in 2024, then advanced by 6.55% to $22.5 million in 2025, then gained by 6.05% to $23.9 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $23.9 million in Q2 2026, $23.8 million in Q1 2026, and $22.5 million in Q4 2025.